InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,227.60
(
0.31%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.51
(
0.46%
)
Bitcoin
65,991.24
(
-0.97%
)
Post# of 302221
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Long_shortguy

Send PM Follow Ignore
Followers 2
Posts 220
Boards Moderated 0
Alias Born 10/03/2019

Long_shortguy

Re: None

Thursday, 07/02/2020 1:17:08 PM

Thursday, July 02, 2020 1:17:08 PM

Post# of 302221
$MMEDF:Mindmed,First Publicly Traded Psychedelics Company

The company is on the brink of beginning phase 2 FDA clinical trials on:
1. LSD micro-dosing for the treatment of adult ADHD
2. Hallucinogenic dose of LSD for the treatment of anxiety disorders
3. 18-MC, a synthetic, non-hallucinogenic derivative of “Ibogaine” for treatment of Opioid addiction/withdrawal

Investor deck

https://assets.website-files.com/5d3ec58873102c610bc714e5/5e5e246853a552ce1be72508_MindMed%20Investor%20Deck.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up